Skip to content

CV

Jump to bottom
C Andrew Basham, PhD edited this page Oct 4, 2024 · 1 revision

The Faculty of Medicine of Harvard University Curriculum Vitae

Date Prepared: October 4, 2024 Name: Christopher Andrew Basham Office: 1620 Tremont Street, Unit 3030, Boston, MA 02120 Email: cv@andrewbasham.com Website: https://andrewbasham.com/ LinkedIn: https://www.linkedin.com/in/candrewbasham/ ORCiD: https://orcid.org/0000-0003-0506-7936 Open Science Framework: https://osf.io/mny8b/ GitHub Profile: https://github.com/CAndrewBasham GitHub Webpage: https://candrewbasham.github.io/web/ ResearchGate: https://www.researchgate.net/profile/C-Andrew-Basham Google Scholar: https://tinyurl.com/3wz4sken

Education: 09/2017-10/2021 PhD Population and Public Health University of British Columbia 09/2010-02/2016 MSc Community Health Sciences University of Manitoba 09/2004-05/2008 BA Environmental/Urban Studies University of Winnipeg

Postdoctoral Training: 03/2022-06/2024 Research Fellow Division of Pharmacoepidemiology and Pharmacoeconomics Harvard Medical School

Appointments at Hospitals/Affiliated Institutions: 03/2022–06/2024 Research Fellow Division of Pharmacoepidemiology and Pharmacoeconomics Brigham and Women's Hospital

Other Professional Positions: Year(s) Position Department Institution 2008-2010 Health Policy Analyst Health Department Manitoba Keewatinowi Okimakanak 2012 Research Assistant Department of Emergency Medicine University of Manitoba 2012-2013 Statistical Analyst First Nations Regional Longitudinal Health Survey Assembly of Manitoba Chiefs 2013 Program Specialist Aboriginal Health Programs Winnipeg Regional Health Authority 2014-2015 Research Assistant Centre for Aboriginal Health Research University of Manitoba 2015 Research Consultant Health Department Manitoba Keewatinowi Okimakanak 2015-2017 Data Analyst Manitoba Centre for Health Policy University of Manitoba 2017-2021 Graduate Research Assistant Tuberculosis Program British Columbia Centre for Disease Control 2018 Teaching Assistant School of Population and Public Health University of British Columbia 2019 Graduate Research Assistant Department of Pathology and Laboratory Medicine University of British Columbia 2020-2021 Graduate Research Assistant Canadian Disability Participation Project University of British Columbia 2021-2022 Evidence Reviewer McGill International TB Centre McGill University 2022- Statistical Consultant Faculty of Health Sciences Simon Fraser University

Committee Service: Local 2022-2024 Lead, Pharmacoequity Team Brigham and Women’s Hospital 2023-2024 Member, Department of Medicine’s Health Equity Innovation Pilot Program Learning Community. Brigham and Women’s Hospital

National 2015-2016 Judge, National Student Conference Canadian Society for Epidemiology and Biostatistics

International 2018-2023 Member, TB and Mental Health Working Group International Union Against TB and Lung Disease 2022-2024 Member, Abstract Committee International Union Against TB and Lung Disease-North America Region 2021-2023 Chair, Global Indigenous Stop TB Initiative International Union Against TB and Lung Disease 2023-2024 Member, Health Equity Special Interest Group International Society for Pharmacoepidemiology 2022-2024 Member, Abstract Committee International Union Against TB and Lung Disease-North America Region 2024 Abstract reviewer, 40th International Conference on Pharmacoepidemiology tInternational Society for Pharmacoepidemiology

Professional Societies 2011-2012 Canadian Association of Health Services and Policy Research 2012-2016 Canadian Society for Epidemiology and Biostatistics 2012- International Union Against Tuberculosis and Lung Disease 2023- International Society of Pharmacoepidemiology

Editorial Activities:
  • Ad hoc Reviewer

American Journal of Public Health; BMJ Open; Canadian Journal of Public Health (x4); Clinical Infectious Disease; Cochrane; Critical Public Health; Global Public Health; Injury Epidemiology (x2); Injury Prevention; International Journal of Tuberculosis and Lung Disease (x2); Journal of General Internal Medicine (x2); Open Forum in Infectious Disease; PLoS One (x2); Postgraduate Medicine; Risk Management and Healthcare Policy; Tropical Medicine and International Health; Virology; Virulence.

Honors and Prizes: 2006 Student of Distinction University of Winnipeg Grade point average 2007 Academic Proficiency Scholarship University of Winnipeg Grade point average 2007 Academic Proficiency Scholarship University of Winnipeg Grade point average 2007 United College Class of ’50 Reunion Scholarship University of Winnipeg Competitive 2007 Manitoba Millennium Scholarship Province of Manitoba Grade point average 2007 Student of Highest Distinction University of Winnipeg Grade point average 2008 Student of Distinction University of Winnipeg Grade point average 2010 Health Services and Policy Research Studentship Western Regional Training Centre Competitive 2010 Network Environment for Aboriginal Health Research Fellowship. Faculty of Medicine, University of Manitoba Competitive 2011-2012 University of Manitoba Graduate Fellowship Manitoba Health Research Council. Competitive 2012 Summer Program in Data Analysis Travel Award York University Competitive 2012 National Student Conference Travel Award Canadian Society of Epidemiology and Biostatistics Competitive 2012 North America Region, 16th Annual Conference Travel Award International Union Against Tuberculosis and Lung Disease Competitive 2017-2018 Graduate Student Initiative Award UBC Faculty of Medicine Competitive 2021 Academic Excellence Initiative PhD Award UBC President’s Office Automatic 2022 Buffalo Blanket Ceremony Communities Alliances and Networks Board of Directors 2023 Research Staff Spotlight Award Brigham Research Institute Nomination 2024 Pillars of Excellence Award Brigham and Women’s Hospital Competitive

Report of Funded and Unfunded Projects Current 10/2023-ongoing “Foundations for Pharmacoequity: missing and misclassified race and ethnicity data in linked Mass General Brigham electronic health record (EHR) and Medicaid/Medicare claims data.” Funding: Brigham and Women's Hospital Health Equity Innovation Pilot HEIP-2023/24 ($40,000). Role: Research Lead. Aims: (1) investigate structural missingness of race and ethnicity in EHR and claims data, comparing missing vs non-missing in terms of sociodemographics, health conditions, healthcare utilization; (2) evaluate concordance of race and ethnicity in claims data compared with EHR data taking into account missingness; (3) thoroughly document race and ethnicity variables available in Medicare and Medicaid benefits and enrolment files and Mass General Brigham (MGB) EHR. 10/2023-ongoing “Multilevel drug utilization trend analysis: a reproducible R and SAS tutorial.” Funding: None. Role: Principal Investigator. Aims: (1) create a tutorial on multilevel and mixed effects modeling of aggregate count data that estimates trends for numerous aggregating units (e.g., states) that is reproducible with open source R code provided freely through a public GitHub repository; (2) develop a participatory workshop that can train, and (3) build an online learning community for mixed effect and multilevel modelling in pharmacoepidemiology. 01/2021-ongoing (unfunded) “Survivorship Epidemiology”. Funding: None. Aims: The purpose of survivorship epidemiology is to share knowledge and advance theory and methods across fields of medicine (critical care, oncology, and infectious disease) in which survivorship is studied quantitatively; creating a critical mass of epidemiologists across fields dedicated to methodological research for survivorship. I propose to mix causal inference quantitative theory and methods with the rich qualitative work done on survivorship within fields and to build bridges across fields to identify generalizable strategies, methods, and tools to address common problems such as comparator selection, decomposing the causal effects of critical illness in terms of physical illness effects, treatment effects, socioeconomic repercussions, and the psychological ramifications of surviving critical illnesses.

Report of Local Teaching and Training Local Invited presentations (last 3 years):

No presentations below were sponsored by 3rd parties/outside entities.

07/2021 Towards survivorship epidemiology: a post-doctoral fellowship application / Oral

Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA 12/2022 Trends and characteristics of tramadol utilization in the United States, 2004-2021 / Oral Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA 03/2023 Diseases as drugs: a target trial emulation framework for survivorship epidemiology? / Oral Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA 05/2023 Multiple-Bias Sensitivity Analysis using Bounds / Journal Club Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA 10/2023 Foundations for Pharmacoequity: Missing and misclassified race and ethnicity in linked electronic health records and Medicare and Medicaid claims data, 2000-2020 / Oral. Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA 04/2024 Race and ethnicity in causal diagrams of health disparities and in clinical prediction modelling: a journal club-style presentation of recent guidance from Howe et al. (2022) and Basu (2023) Health Equity Innovation Pilot (HEIP) Program Learning Community, Dept of Medicine, Brigham and Women’s Hospital, Boston, MA. 05/2024 Missing and discordant race and ethnicity variable values in linked MGB EHR–CMS claims data, 2015-2019: a descriptive investigation. Health Equity Innovation Pilot (HEIP) Program Learning Community, Dept of Medicine, Brigham and Women’s Hospital, Boston, MA.

Report of Regional, National and International Invited Teaching and presentations Those presentations below sponsored by outside entities are so noted and the sponsor(s) is (are) identified.

Regional 03/2021

“All together now: aggregating multiple records to develop a person-based dataset to integrate and enhance infectious disease surveillance in Ontario, Canada” / Oral. Canadian Public Health Association Journal Club, Online.

International 06/2011 Tuberculosis Incidence in Six Canadian Provinces, 1996-2009: Ethnic-origin specific rate ratios and trends. Korean Institute of Tuberculosis, Osong, South Korea, June 22, 2011 (Oral). 03/2021 “An overview of systematic reviews with a focus on depression” / Invited Presentation. In, World TB Day Webinar: Integrating TB and Mental Health Services to End the Epidemic. TB-Mental Health Working Group, International Union Against Tuberculosis and Lung Disease. https://youtu.be/eDH98iF-CBo?si=6Ly-mxjm9XxADTmc. 08/2023 Tramadol use in the United States, 2005-2021. / Selected Oral Abstract. 39th International Conference on Pharmacoepidemiology, Halifax, Canada. [grant funding from AHRQ supported travel, accommodations, and registration].

Report of Teaching and Education Innovations Causing Careers: a causal inference approach to planning education and training exposures aimed at achieving long-term work and life goals as mediated by real-world experiences. Causing careers has three objectives: (1) educating trainees in causal inference, (2) formalizing career planning through causal inference framework terminology, applying epidemiological concepts with methodological tools such as DAGs, PICOs, 2x2 tables, and basic probability theory while introducing counterfactual reasoning within the potential outcomes framework, and (3) contributing to the epidemiology’s scant pedagogical research. A key implement for Causing Careers will be self-directed acyclic graphs (self-DAGs). Self-DAGs create immediate relevance for learning DAGs by focusing on each individuals career goals (long-term and intermediate positions as outcomes). By explicitly linking education and/or training exposures/interventions assumed to causative (necessarily or sufficiently) or at least contribute substantially) to realizing career outcomes. Potential confounding factors (time-varying or baseline with fixed effects or interactions with education exposure or third variable(s), as assumed with rationale provided by the trainee). These may affect both their education/training and career outcomes which can be discussed in terms of subject matter and in training students to understand differences between confounding, mediating, and other variables. Trainees that can identify potential confounding on their career and education pathways may devise approaches to “adjust” away or otherwise block all backdoor paths between education exposure and career outcome). Furthermore, baseline effect modification of the education/training can be included in text descriptions developed alongside the career causal graphs. Using publicly available Daggity.net software (https://dagitty.net/) trainees will draw these career DAGs or self-DAGs that identify their specific, measurable, achievable, relevant, and timebound (SMART) career goals (outcomes) and will describe educational interventions (exposures) to cause this goal. A starting exercise will be considering the Causing Career’s first goal of causal inference education, where we describe the concepts that define intended outcomes of the course.

Report of Education of Patients and Service to the Community Those presentations below sponsored by outside entities are so noted and the sponsor(s) is (are) identified. Activities Years Role Organization Sponsor 2004 Candidate, Member of Parliament (Canada) Green Party of Canada Green Party of Canada 2004-2006 Policy and Platform Development Committee Green Party of Canada Volunteer 2005-2006 Secretary Green Party of Manitoba Volunteer 2005-2006 Membership Development Coordinator Green Party of Manitoba Volunteer 2006-2007 Board Member Manitoba EcoNetwork, Inc. Volunteer 2007 Candidate, Member of the Legislative Assembly (Manitoba) Green Party of Manitoba Green Party of Manitoba 2006-2008 Leader Green Party of Manitoba Volunteer 2008 National Delegate 3rd Global Greens Congress Green Party of Canada

Educational Material for Patients the Lay Community: 03/2023 TB or not TB? What’s Happening in the Body. One Vision, Many Paths: Indigenous Solutions for Tuberculosis and HIV. Communities Alliances and Networks.

Recognition: 2004 U of W goes greener as it looks to the future Winnipeg Free Press 2005 The SunSet project Alma Mater Society of UBC 2006 U of W student to lead Green Party Winnipeg Free Press 2007 Greens promise ban on cosmetic pesticides Winnipeg Free Press 2022 Global Indigenous Stop TB Initiative: A TB Scientific Section Working Group International Union Against TB And Lung Disease 2023 Team of Brigham Investigators Receive Department of Medicine Health Equity Innovation Pilot Award Brigham and Women’s Hospital

Report of Scholarship (ORCiD: https://orcid.org/0000-0003-0506-7936) * denotes equal authorship contribution ** denotes mentored trainee.

Peer-Reviewed Scholarship in print or other media:

Research Investigations
  1. Basham CA, Snider C. Homicide mortality rates in Canada, 2000–2009: Youth at increased risk. Can J Public Heal. 2016;107(3):239. doi:10.17269/cjph.107.5391
  2. Basham CA, Elias B, Fanning A, Cook C, Orr P. Performance measurement of a Canadian provincial tuberculosis programme: Manitoba, 2008–2012. Int J Tuberc Lung Dis. 2018;22(4):437–443. doi:10.5588/ijtld.17.0508
  3. Romanowski K, Baumann B, Basham CA, Ahmad Khan F, Fox GJ, Johnston JC. Long–term all–cause mortality in people treated for tuberculosis: a systematic review and meta–analysis. Lancet Infect Dis. 2019;19:1129–1137. doi:10.1016/S1473–3099(19)30309–3
  4. Plourde PJ, Basham CA, Derksen S, et al. Latent tuberculosis treatment completion rates from prescription drug administrative data. Can J Public Heal. 2019;110(6):705–713. doi:10.17269/s41997–019–00240–1
  5. Basham CA, Elias B, Fanning A, Orr P. Tuberculosis among northern Manitoba First Nations, 2008–2012: program performance on– and off–reserve. Canadian Journal of Public Health 2019;110(6):688–696.
  6. Basham CA, Karim ME. Multimorbidity prevalence in Canada: a comparison of Northern Territories with Provinces, 2013/14. International Journal of Circumpolar Health. 2019;78(1):1607703.
  7. Basham CA, Smith S, Romanowski K, Johnston JC. Cardiovascular morbidity and mortality among people diagnosed with tuberculosis: a systematic review and meta-analysis. PLoS ONE 15(7):e0235821.
  8. Basham CA, Cook, VJ, Johnston JC. Towards a ‘fourth 90’: A population–based analysis of post–tuberculosis pulmonary function testing in British Columbia, Canada, 1985–2015. European Respiratory Journal. April 2020:2000384.
  9. Basham CA. Regional variation in multimorbidity prevalence in British Columbia, Canada: a cross–sectional analysis of Canadian Community Health Survey data, 2015/16. Health Promotion and Chronic Disease Prevention in Canada. 2020 Aug;40(7–8):225–234.
  10. Basham CA, Karim ME, Cook VJ, Patrick DM, Johnston JC. Post–tuberculosis mortality risk among immigrants to British Columbia, Canada, 1985–2015: a time–dependent Cox regression analysis of linked immigration, public health, and vital statistics data. Can J Public Heal. 2021;112(1):132–141.
  11. Basham CA, Karim ME, Cook, VJ, Patrick DM, Johnston JC. Post–tuberculosis airway disease among people immigrating to British Columbia, Canada, 1985–2015: a population–based cohort study. EClinicalMedicine. 2021;33:100752.
  12. Nikiforuk A, Kuchinski S, Twa DW, Lukac CD, Sbihi H, Basham CA, Steidl C, Prystajecky NA, Jassem A, Krajden M, Patrick DM, Sekirov I. The Contrasting Role of Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Transcription in SARS-CoV-2 Infection: A Cross-Sectional Study of People Tested for COVID-19 in British Columbia, Canada. EBioMedicine. 2021;66:103316.
  13. Basham CA, Karim ME, Cook, VJ, Patrick DM, Johnston JC. Tuberculosis–associated depression risk: a population–based cohort study of people immigrating to British Columbia, Canada, 1985–2015. Annals of Epidemiology. 2021; 63: 7-14.
  14. Basham CA, Karim ME. An E–value analysis of potential unmeasured or residual confounding in systematic reviews of post–TB mortality, respiratory disease, and cardiovascular disease. Annals of Epidemiology. 2022; 68: 24-31.
  15. Basham CA, Karim ME, Johnston JC. Multimorbidity prevalence and chronic disease patterns among tuberculosis survivors in a high-income setting. Can J Public Heal. 2023 Apr;114(2):264-276.
  16. Vadlamudi NK, Basham CA, Johnston JC, Ahmad Khan F, Battista Migliori G, Centis R, D'Ambrosio L, Jassat W, Davies MA, Schwartzman K, Campbell JR. The association of SARS-CoV-2 infection and tuberculosis disease with unfavorable treatment outcomes: A systematic review. PLOS Glob Public Health. 2023 Jul 19;3(7):e0002163.
  17. Martin Ginis KA, Sinden AR, Bonaccio S, Labbé D, Guertin C, Gellatly IR, Koch L, Mortenson BW, Routhier F, Basham CA, Jetha A, Miller WC. Experiential Aspects of Participation in Employment and Mobility for Adults With Physical Disabilities: Testing Cross-Sectional Models of Contextual Influences and Well-Being Outcomes. Archives of Physical Medicine and Rehabilitation. Published online August 20, 2023:S0003-9993(23)00462-8. doi:10.1016/j.apmr.2023.08.004
  18. Closson K, Zulu B, Jesson J, Dietrich JJ, Pakhomova T, Basham CA, Beksinska M, Kaida A. Examining gender and sexual orientation differences in physical intimate partner violence experienced and perpetrated by youth living in eThekwini district South Africa during the COVID-19 pandemic. BMC Public Health. 2023 Nov 21;23(1):2300.
  19. Zharima C. (co-first)*, Singh R. (co-first)*, Closson K., Beksinska M., Zulu B., Jesson J., Pakhomova T., Dong E., Dietrich J., Kaida A., Basham CA (senior). Economic hardship and perpetration of intimate partner violence by young men in South Africa during the COVID-19 pandemic (2021–2022): a cross-sectional study. Inj. Epidemiol. 2024. 11(2). https://doi.org/10.1186/s40621-024-00483-8.
  20. Jesson J, Zulu B, Closson K, Basham CA, Beksinska M, Dong E, Zharima C, Singh R, Pakhomova T, Dietrich J, Kaida A. Increased difficulty accessing food and income change during the COVID-19 pandemic among youth living in the eThekwini district, South Africa. Public Health Nutrition. Published online 2024:1-30. doi:10.1017/S1368980024001174.
  21. Basham CA, Edrees H, Huybrechts KF, Hwang CS, Bateman BT, Bykov K. Tramadol use in U.S. adults with commercial health insurance, 2005-2021. American Journal of Preventive Medicine. Published online June 12, 2024. doi:10.1016/j.amepre.2024.06.009
  22. Bea S, Huybrechts KF, Edrees HH, Basham CA, Vine SM, Glynn RJ, Bateman BT, Bykov K. Opioid overdose in patients with concomitant use of tramadol and clopidogrel versus alternative antiplatelet agents. J Am Coll Cardiol. 2024 (Accepted)
Other peer-reviewed scholarship
  1. Basham CA, Romanowski K, Johnston JC. Life after tuberculosis: planning for health. Lancet Respiratory Medicine. 2019;7(12):1004–1006.
  2. Basham CA, Grewal N, Orr PH, McMullin K, Wobeser WL. What will it take to achieve meaningful action on tuberculosis among Indigenous Peoples? International Journal of Tuberculosis and Lung Disease. 2020;24(5):661–664
  3. Basham CA. Post–tuberculosis outcomes science: a sub–discipline for TB survivorship research? International Journal of Tuberculosis and Lung Disease. 2021; 25(6):498-501.

Non-peer reviewed scholarship in print or other media: Letters to the Editor

  1. Basham CA, Elias B, Orr P. Tuberculosis elimination in Canada. Lancet. 2019;394(10195):300–301. doi:10.1016/S0140–6736(19)31122–5
  2. Basham CA, Romanowski K, Johnston JC. Cardiovascular disease: the forgotten cousin of post-TB health? Int J Tuberc Lung Dis. 2020 Apr 1;24(4):466-467. doi: 10.5588/ijtld.19.0795. PMID: 32317076.
  3. Basham CA, Romanowski K, Johnston JC. Alcohol use disorder and TB survivor health: correspondence on Necho et al.’s systematic review. International Journal of Tuberculosis and Lung Disease. 2021;25(6):516-517.
  4. Basham CA, Orr PH. Monitoring TB program performance. Int J Tuberc Lung Dis. 2022 Jul 1;26(7):692-693.
Theses:
  1. Basham CA. Tuberculosis Prevention, Diagnosis, and Care: Manitoba, 2008-2010: A Performance Analysis. MSc Thesis: Department of Community Health Sciences, University of Manitoba. Approved: Jan. 2021.
  2. Basham CA. Tuberculosis Survivor Health. PhD Thesis: School of Population and Public Health, University of British Columbia. Approved: October 2021. Retrieved October 1, 2023 from: https://open.library.ubc.ca/collections/ubctheses/24/items/1.0402446.
Abstracts, Poster presentations, and Exhibits at Professional Meetings (past 3 years, not yet published as peer-reviewed articles):
  1. Basham CA, Edrees H, Vine S, Mastrorilli J, Oduol T, Bateman B, Glynn R, Huybrechts K, Bykov K. A cohort study of opioid overdose risk after oxycodone initiation during CYP3A4-inhibiting vs non-inhibiting calcium channel blocker therapy: United States, 2000-2020. The 39th International Conference on Pharmacoepidemiology. August 23-27, 2023. Halifax, Canada. [poster]
  2. Bykov K, Basham CA, Khan N, Vine S, Edrees H, Mastrorilli J, Bateman B, Glynn R, Huybrechts K. Risk of Opioid Overdose with Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors. The 39th International Conference on Pharmacoepidemiology. August 23-27, 2023. Halifax, Canada. [selected oral abstract presentation by KB].
  3. Oduol T, Basham CA. Missing Race and Ethnicity Data in Medicaid: A Multilevel Analysis of Trends by State (2016-2022). The International Society for Pharmacoepidemiology Mid-Year Meeting. https://www.pharmacoepi.org/meetings/2024mym/agenda/oral-presentations-and-posters/ April 14-16, 2024. Miami, Florida. [selected oral abstract presentation by TO]
  4. Basham CA, Oduol T, Weberpals J, Hwang C, Rome B. Race and Ethnicity Variables in Real-World Data: Implications for Reproducibility in Pharmacoepidemiology. The 40th International Conference on Pharmacoepidemiology (ICPE). August 24-28, 2024. Berlin, Germany. [poster]
  5. Basham CA, Hyubrechts K, Batemen, B, Vine S, Edrees H, Glynn R, Bykov, K. Co-Administration of Oxycodone and CYP3A4-Inhibiting Calcium Channel Blockers and Opioid Overdose: Real-World Evidence from Population-based Claims Data in the United States, 2000-2020. The 40th International Conference on Pharmacoepidemiology (ICPE). August 24-28, 2024. Berlin, Germany. [poster]
Reports:
  1. MKO Health. Policy Analysis and Position Paper on Non-alcohol-based hand sanitizer for Northern Manitoba First Nations during the H1N1 Pandemic. Manitoba Keewatinowi Okimakanak, Inc. Thompson, Manitoba. (ed to Health Canada – First Nations and Inuit Health Branch). 2009.
  2. MKO Health. Statistical Analysis of Northern Manitoba First Nations Housing. Manitoba Keewatinowi Okimakanak, Inc. Thompson, Manitoba. 2009.
  3. MKO Health. Briefing Note on Methicillin Resistant Staphylococcus Aureus (MRSA) in Northern Manitoba First Nations. Manitoba Keewatinowi Okimakanak, Inc. Winnipeg, Manitoba. (ed to Manitoba Health and Health Canada First Nations and Inuit Health Branch). 2009. [Description: analysis of monthly communicable disease reports and literature review to find potential solutions].
  4. MKO Health. Policy Analysis of Differential Response to H1N1 in Northern Manitoba First Nations compared to Northern Ontario First Nations. Manitoba Keewatinowi Okimakanak, Inc. Winnipeg, Manitoba. (Used for internal planning regarding and best practices for community leadership and political advocacy regarding oseltamivir and zanamivir). 2010.
  5. Assembly of Manitoba Chiefs (AMC), First Nations Regional Health Survey (RHS) Phase 2 (2008- 2010): Manitoba Regional Report. Winnipeg: Assembly of Manitoba Chiefs, June 2012 (Revised November 2012). https://web.archive.org/web/20170612153018/http://www.fnhssm.com/images/PDF/rhs-survey-2008-10-regional-report.pdf.
  6. Lix LM, Plourde PJ, Larcombe L, Kinew KA, Basham CA, Derksen S, Srisakuldee W, Schultz J, and McCulloch S. Exploring Tuberculosis Treatment, Management, and Prevention in Manitoba’s Administrative Health Data. Winnipeg, MB. Manitoba Centre for Health Policy. Autumn 2018. http://mchp-appserv.cpe.umanitoba.ca/reference/MBTB_Report_web.pdf
  7. Katz A, Kinew KA, Star L, Taylor C, Koseva I, Lavoie J, Burchill C, Urquia ML, Basham CA, Rajotte L, Ramayanam V, Jarmasz J, Burchill S. The Health Status of and Access to Healthcare by Registered First Nation Peoples in Manitoba. Winnipeg, MB. Manitoba Centre for Health Policy. Fall 2019. https://mchp-appserv.cpe.umanitoba.ca/reference/FN_Report_web.pdf

Clone this wiki locally